Crossmark

Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers

Crossref DOI link: https://doi.org/10.1038/s41401-018-0019-5

Published Online: 2018-05-18

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Qing-rou

Zhao, Hui

Zhang, Xue-sai

Lang, Henk

Yu, Ker
License Information

Text and Data Mining valid from 2018-05-18
More Information

Article History

Received: 20 September 2017

Revised: 31 January 2018

Accepted: 11 February 2018

First Online: 18 May 2018

Competing interests

: The authors declare no competing interests.